Synergistic Activation of the Fibroblast Growth Factor 4 Enhancer by Sox2 and Oct-3 Depends on Protein-Protein Interactions Facilitated by a Specific Spatial Arrangement of Factor Binding Sites

REFERENCES

• Aurora, R., and W. Herr. 1992. Segments of the POU domain influence one another’s DNA-binding specificity. Mol. Cell. Biol. 12:455–467.
   PubMedGoogle Scholar
• Brehm, A., K. Ohbo, and H. Scholer. 1997. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol. Cell. Biol. 17:154–162.
   PubMedGoogle Scholar
• Carlsson, P., M. L. Waterman, and K. A. Jones. 1993. The hLEF/TCF-1a HMG protein contains a context-dependent transcriptional activation domain that induces the TCRa enhancer in T cells. Genes Dev. 7:2418–2430.
   PubMedGoogle Scholar
• Curatola, A. M., and C. Basilico. 1990. Expression of the K-fgf protooncogene is controlled by 3′ regulatory elements which are specific for embryonal carcinoma cells. Mol. Cell. Biol. 10:2475–2484.
   PubMedGoogle Scholar
• Dailey, L., H. Yuan, and C. Basilico. 1994. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol. Cell. Biol. 14:7758–7769.
   PubMedGoogle Scholar
• Delli Bovi, P., A. M. Curatola, F. G. Kern, A. Greco, M. Ittmann, and C. Basilico. 1987. An oncogene isolated by transfection of Kaposi’s sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50:729–737.
   PubMed Web of Science ®Google Scholar
• Denny, P., S. Swift, F. Connor, and A. Ashworth. 1992. An SRY-related gene expressed during spermatogenesis in the mouse encodes a sequence-specific DNA binding protein. EMBO J. 11:3705–3712.
   PubMedGoogle Scholar
• Feldman, B., W. Poueymirou, V. E. Papaioannou, T. M. DeChiara, and M. Goldfarb. 1995. Requirement of FGF-4 for post-implantation mouse development. Science 267:246–250.
   PubMed Web of Science ®Google Scholar
• Giese, K., and R. Grosschedl. 1993. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J. 12:4667–4676.
   PubMedGoogle Scholar
• Gstaiger, M., L. Knoepfel, O. Georgiev, W. Schaffner, and C. M. Hovens. 1995. A B-cell coactivator of octamer-binding transcription factors. Nature 373:360–362.
   PubMed Web of Science ®Google Scholar
• Gstaiger, M., O. Geoegiev, H. van Leeuwen, P. van der Vliet, and W. Schaffner. 1996. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation. EMBO J. 15:2781–2790.
   PubMedGoogle Scholar
• Gubbay, J., J. Collignon, P. Koopman, B. Capel, A. Economou, A. Munsterberg, N. Vivian, P. N. Goodfellow, and R. Lovell-Badge. 1990. A gene mapping to the sex-determining region of the mouse Y-chromosome is a member of a novel family of embryonically expressed genes. Nature 346:245–250.
   PubMed Web of Science ®Google Scholar
• Herskowitz, I. 1989. A regulatory hierarchy for cell specialization in yeast. Nature 342:749–757.
   PubMed Web of Science ®Google Scholar
• Huang, C. C., and W. Herr. 1996. Differential control of transcription by homologous homeodomain coregulators. Mol. Cell. Biol. 16:2967–2976.
   PubMedGoogle Scholar
• Imagawa, M., A. Miyamoto, M. Shirakawa, H. Hamada, and M. Muramatsu. 1991. Stringent integrity requirements for both trans-activation and DNA-binding in a transactivator, Oct3. Nucleic Acids Res. 19:4503–4508.
   PubMedGoogle Scholar
• Jin, Y., J. Mead, T. Li, C. Wolberger, and A. K. Vershon. 1995. Altered DNA recognition and bending by insertions in the a2 tail of the yeast a1/a2 homeodomain heterodimer. Science 270:290–293.
   PubMedGoogle Scholar
• Kamachi, Y., S. Sockanathan, Q. Liu, M. Breitman, R. Lovell-Badge, and H. Kondoh. 1995. Involvement of Sox proteins in lens-specific activation of crystallin genes. EMBO J. 14:3510–3519.
   PubMedGoogle Scholar
• Lai, J.-S., and W. Herr. 1992. EtBr provides a simple tool for identifying genuine DNA-independent protein associations. Proc. Natl. Acad. Sci. USA 89:6958–6962.
   PubMed Web of Science ®Google Scholar
• Lai, J.-S., M. A. Cleary, and W. Herr. 1992. A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. Genes Dev. 6:2058–2065.
   PubMedGoogle Scholar
• Lefstin, J. A., J. R. Thomas, and K. R. Yamamoto. 1994. Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev. 8:2842–2856.
   PubMed Web of Science ®Google Scholar
• Leger, H., E. Sock, K. Renner, F. Grummt, and M. Wegner. 1995. Functional interaction between the POU domain protein Tst-1/Oct-6 and the highmobility-group protein HMG-I/Y. Mol. Cell. Biol. 15:3738–3747.
   PubMedGoogle Scholar
• Luo, Y., and R. G. Roeder. 1995. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15:4115–4124.
   PubMed Web of Science ®Google Scholar
• Mann, R., and S.-K. Chan. 1996. Extra specificity from extradenticle: the partnership between HOX and PBX/EXD homeodomain proteins. Trends Genet. 12:258–262.
   PubMed Web of Science ®Google Scholar
• Niswander, L., and G. Martin. 1992. Fgf-4 expression during gastrulation, myogenesis, limb, and tooth development in the mouse. Development 114:755–768.
   PubMed Web of Science ®Google Scholar
• Niswander, L., C. Tickel, A. Vogel, I. Booth, and G. R. Martin. 1993. FGF-4 replaces the apical ectodermal ridge and directs outgrowth and patterning of the limb. Cell 75:579–587.
   PubMed Web of Science ®Google Scholar
• Okamoto, K., H. Okazawa, A. Okuda, M. Sakai, M. Muramatsu, and H. Hamada. 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60:461–472.
   PubMed Web of Science ®Google Scholar
• Perkins, N. D., N. L. Edwards, C. S. Duckett, A. B. Agranoff, R. M. Schmid, and G. J. Nabel. 1993. A cooperative interaction between NF-kB and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12:3551–3558.
   PubMed Web of Science ®Google Scholar
• Perlmann, T., P. N. Rangarajan, K. Umesono, and R. Evans. 1993. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 7:1411–1422.
   PubMed Web of Science ®Google Scholar
• Pomerantz, J. L., T. M. Kristie, and P. A. Sharp. 1992. Recognition of the surface of a homeo domain protein. Genes Dev. 6:2047–2057.
   PubMedGoogle Scholar
• Scholer, H. R. 1991. Octamania: the POU factors in mouse development. Trends Genet. 7:323–329.
   PubMed Web of Science ®Google Scholar
• Sinclair, A. H., P. Berta, M. S. Palmer, J. R. Hawkins, B. L. Griffiths, D. J. Smith, J. W. Foster, A. Frischaux, R. Lovell-Badge, and P. N. Goodfellow. 1990. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240–244.
   PubMed Web of Science ®Google Scholar
• Stern, S., M. Tanaka, and W. Herr. 1989. The Oct-1 homeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. Nature 341:624–630.
   PubMed Web of Science ®Google Scholar
• Strubin, M., J. W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80:497–506.
   PubMed Web of Science ®Google Scholar
• Sturm, R. A., G. Das, and W. Herr. 1988. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeobox subdomain. Genes Dev. 2:1582–1599.
   PubMed Web of Science ®Google Scholar
• Taira, M., T. Yoshida, K. Miyagawa, H. Sakamoto, M. Terada, and T. Sugimura. 1987. cDNA sequence of a human transforming gene hst and identification of the coding sequence required for transforming activity. Proc. Natl. Acad. Sci. USA 84:2980–2984.
   PubMed Web of Science ®Google Scholar
• Tanaka, M., J.-S. Lai, and W. Herr. 1992. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 68:755–767.
   PubMed Web of Science ®Google Scholar
• Travis, A., A. Amsterdam, C. Belanger, and R. Grosschedl. 1991. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function. Genes Dev. 5:880–894.
   PubMed Web of Science ®Google Scholar
• Treisman, R., R. Marais, and J. Wynne. 1992. Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J. 11:4631–4640.
   PubMedGoogle Scholar
• Velcich, A., P. Delli-Bovi, A. Mansukhani, E. B. Ziff, and C. Basilico. 1989. Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. Oncogene Res. 5:31–37.
   PubMedGoogle Scholar
• Verrijzer, C. P., A. Joost, W. M. Oosterhout, and P. C. van der Vliet. 1992. The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins. Mol. Cell. Biol. 12:542–551.
   PubMedGoogle Scholar
• Walker, S., S. Hayes, and P. O’Hare. 1994. Site-specific conformational alteration of the Oct-1 POU domain-DNA complex as the basis for differential recognition by Vmw65 (VP16). Cell 79:841–852.
   PubMedGoogle Scholar
• Waterman, M., and K. Jones. 1990. Purification of TCF-1a, a T-cell-specific transcription factor that activates the T-cell receptor gene enhancer in a context-dependent manner. New Biol. 2:621–636.
   PubMedGoogle Scholar
• Yuan, H., N. Corbi, C. Basilico, and L. Dailey. 1995. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9:2635–2645.
   PubMed Web of Science ®Google Scholar
• Zwilling, S., H. König, and T. Wirth. 1995. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 14:1198–1208.
   PubMedGoogle Scholar